Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aluminum hydroxide (Gaviscon) (1 trial)
gla-lsq (1 trial)
pamvac (1 trial)
Malaria (Phase 1)
Trials (1 total)
Trial APIs (3 total)